CSIMarket
 


Arcturus Therapeutics Holdings Inc   (ARCT)
Other Ticker:  
 

Cumulative Arcturus Therapeutics Holdings Inc 's Leverage Ratio for Trailing Twelve Months Period

ARCT's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

ARCT Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth 92.26 % 67.05 % 78.21 % 18.45 % -43.79 %
Y / Y Total Liabilities Growth 28.98 % -12.48 % -26.6 % -6.4 % -31.52 %
Leverage Ratio for Trailing Twelve Months Period 0.46 0.48 0.56 0.72 0.77
Total Ranking # 1061 # 1214 # 1443 # 1939 # 1888
Seq. Equity Growth -1.79 % -13.39 % 21.8 % 85.57 % -14.67 %
Seq. Total Liabilities Growth 28.3 % 4.39 % -24.98 % 28.37 % -12.94 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite net new borrowings of 28.3% Arcturus Therapeutics Holdings Inc managed to decrease Leverage Ratio for Trailing Twelve Months Period in III. Quarter to 0.46, below Arcturus Therapeutics Holdings Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 240 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Arcturus Therapeutics Holdings Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are ARCT's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 241
Sector # 448
S&P 500 # 1041


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.53 1.02 0.33
(Jun 30 2019)   0




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Ibio inc   1.25 
Prestige Consumer Healthcare Inc   1.23 
Ani Pharmaceuticals Inc  1.22 
Oncorus Inc   1.21 
Johnson and Johnson  1.19 
Biolinerx Ltd   1.19 
Cerevel Therapeutics Holdings Inc   1.19 
Perrigo Company Plc  1.17 
Advaxis Inc   1.16 
Pfizer Inc  1.15 
Sigilon Therapeutics Inc   1.14 
Nektar Therapeutics  1.14 
Equillium Inc   1.13 
Lifevantage Corp  1.10 
Royalty Pharma Plc  1.09 
Veru Inc   1.09 
2seventy Bio Inc   1.07 
Can fite Biopharma Ltd   1.07 
Uniqure N v   1.06 
Elanco Animal Health Inc  1.05 
Novartis Ag  1.05 
Pacira Biosciences inc   1.04 
Rani Therapeutics Holdings Inc   1.02 
Otonomy Inc   1.02 
Atreca inc   1.00 
Oncotelic Therapeutics Inc   1.00 
Transcode Therapeutics Inc   0.98 
Amphastar Pharmaceuticals Inc   0.98 
Inhibitor Therapeutics Inc   0.95 
Cartesian Therapeutics Inc   0.94 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com